{"url": "http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2013/ucm354493.htm", "query": "black salve", "actual-search-type": "n", "contents": " \r\n\t\t\r\n\t\t\r\n\t\t \r\n\t\r\n\t\r\n\r\n \r\n\t<!DOCTYPE html PUBLIC \"-//W3C//DTD HTML 4.01 Transitional//EN\" \"http://www.w3c.org/TR/1999/REC-html401-19991224/loose.dtd\">\r\n<html lang=\"en\" xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:addthis=\"http://www.addthis.com/help/api-spec\">\r\n<head><meta http-equiv=\"X-UA-Compatible\" content=\"IE=7\" />\r\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\r\n\r\n      <title>Altasource LLC DBA Metalabs LLC 2/25/13</title> \r\n\t<meta name=\"ID\" content=\"UCM354493\"/>\r\n\t<meta name=\"msvalidate.01\" content=\"0AE61A039CC5BDCCF556A11C18A61D44\" />\r\n\t<meta name=\"dc.title\" content=\"2013 - Altasource LLC DBA Metalabs LLC 2/25/13\"/>\r\n\t<meta name=\"dc.type\" content=\"WebContent\"/>\r\n\t<meta name=\"dc.description\" content=\"Unapproved and Misbranded New Drugs\"/>\r\n\t<meta name=\"dc.language\" content=\"en\"/>\r\n\t<meta name=\"posted\" content=\"2013-06-04\"/>\r\n\t<meta name=\"index_date\" content=\"2016-09-27\"/>\r\n\t<meta name=\"keywords\" content=\"Respiratory Response\r\nAfrican Mango\r\nCoffee Black Salve\r\nMeta-Cell\"/>\r\n\t<meta name=\"description\" content=\"Unapproved and Misbranded New Drugs\"/>\r\n\t<meta name=\"dc.publisher\" content=\"\"/>\r\n\t<meta name=\"dc.audience\" content=\"\"/>\r\n\t<meta name=\"dc.creator\" content=\"\"/>\r\n\t<meta name=\"old_url\" content=\"\"/>\r\n\t<meta name=\"archive\" content=\"No\"/>\r\n\r\n\r\n\r\n\t<meta name=\"search_topic\" content=\"Warning Letters|Drugs\"/>\r\n\t\r\n\t\t<meta name=\"companyname\" content=\"Altasource LLC DBA Metalabs LLC\"/>\r\n\t\t<meta name=\"issuingoffice\" content=\"Atlanta District Office\"/>\r\n\t\t<meta name=\"letterissuedate\" content=\"2013-02-25\"/>\r\n\t\t<meta name=\"closeoutdate\" content=\"\"/>\r\n\t\t<meta name=\"hascloseoutletter\" content=\"No\"/>\r\n\t\t<meta name=\"hasresponseletter\" content=\"No\"/>\r\n\t\t<meta name=\"hasposteddate\" content=\"9/13/13 1:58 PM\"/>\t\r\n\t\t<meta name=\"dc.subject\" content=\"Unapproved and Misbranded New Drugs\"/>\r\n\t\t\t\r\n\t<script language=\"JavaScript\" type=\"text/javascript\">\r\n\tdocument.title = \"2013\" + \" > \" + \"Altasource LLC DBA Metalabs LLC 2/25/13\";</script>\r\n\t<meta name=\"google-site-verification\" content=\"wxQkNTrqmvYnwVcNzA2mspBp7EDErzIhAzyX-YvvRWI\" /> \r\n \r\n \r\n\r\n<!--- /**** Begin CSS References ****/-->\r\n \r\n\t<link rel=\"stylesheet\" type=\"text/css\" media=\"screen\" href=\"/ucm/groups/fdagov-public/@system/documents/system/css_fda_gov_stylesheet.css\" />\r\n\t<link rel=\"stylesheet\" type=\"text/css\" media=\"print\" href=\"/ucm/groups/fdagov-public/@system/documents/system/css_fda_gov_print_stylesheet.css\" />\r\n\t<!--[if lt IE 9]>\r\n\t<link rel=\"stylesheet\" type=\"text/css\" media=\"screen\" href=\"/ucm/groups/fdagov-public/@system/documents/system/css_fda_gov_stylesheet_ie.css\" />\r\n\t<![endif]-->\r\n\t<link rel=\"stylesheet\" type=\"text/css\" href=\"/ucm/groups/fdagov-public/@system/documents/system/css_footable_stylesheet.css\" /> \r\n\t<!--- /**** Begin Sitewide JS References ****/-->\r\n\t<script type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_jquery_10.js\"></script>\r\n\t<!-- ## ADDED tips Javascript reference to handle styling the tool tips ## -->\r\n\r\n\t<script type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_tips_min.js\"></script>\r\n\t<script type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_global.js\"></script>\r\n\t<script type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_resize_min.js\"></script>\r\n\t<script type=\"text/javascript\" src=\"https://ajax.googleapis.com/ajax/libs/jqueryui/1.8.18/jquery-ui.min.js\" ></script>\r\n\t<script type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/highcharts.js\" ></script>\r\n\t<!-- ## ADDED hoverIntent JavaScript to support the drop-down menus ## -->\r\n\t<script type=\"text/JavaScript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_jquery_hover_intent_min.js\"></script>\r\n\t<!-- ## ADDED submenus JavaScript reference to import code to handle displaying sub-menus when hovered over ## -->\r\n\t<script type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_submenus_min.js\"></script>\r\n\t<script type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_jquery_tablesort_min.js\"></script>\r\n\t<script type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_footable_scripts.js\"></script>\r\n\t \t\t\r\n\t\r\n\t<!-- ## For guidances dynamic list ## --> \r\n\t\t\t<script type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_jquery_tablepagination_min.js\"></script> \r\n\t\t<script type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_sorttable_fdagov.js\"></script>\r\n<!-- Google Auto Suggest-->\r\n  <link rel=\"stylesheet\" type=\"text/css\" media=\"screen\" href=\"/ucm/groups/fdagov-public/@system/documents/system/css_fdagov_googlesuggest.css\" />\r\n  <script type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_googlesuggest.js\"></script>\r\n<!--END  Google Auto Suggest-->\r\n\r\n<!--- /**** FEATURE SECTION ****/-->\t\r\n<!--- /**** SUBTOPIC/CONTENT SECTION ****/-->\r\n\t<!--[if lt IE 7]>\r\n\t\t<script defer type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_pngfix_fdagov.js\"></script>\r\n\t<![endif]-->\r\n\t<!-- ## ADDED hovers Javascript reference to handle hovering over images and replacing that image with it's hover effect ## -->\r\n\t\t<script type=\"text/javascript\" src=\"/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_hovers.js\"></script>\r\n\t \r\n\t\r\n\t<script type=\"text/javascript\" src=\"/foresee/foresee-trigger.js\" language=\"JavaScript\"></script> \r\n\t\r\n\t<script type=\"text/javascript\"> \r\n\tsetTimeout(function(){var a=document.createElement(\"script\"); \r\n\tvar b=document.getElementsByTagName(\"script\")[0]; \r\n\ta.src=document.location.protocol+\"//script.crazyegg.com/pages/scripts/0024/3700.js?\"+Math.floor(new Date().getTime()/3600000);\r\n\t a.async=true;a.type=\"text/javascript\";b.parentNode.insertBefore(a,b)}, 1); \r\n\t</script> \r\n\t<script>\r\n\t  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){\r\n\t  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),\r\n\t  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)\r\n\t  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');\r\n\r\n\t\r\n\t  ga('create', 'UA-22737364-1', 'auto');\r\n\t  ga('send', 'pageview');\r\n\t\r\n\t</script>\r\n\r\n\t<!-- DAP Code -->\r\n\t<script language=\"javascript\" id=\"_fed_an_ua_tag\" src=\"https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=HHS&subagency=FDA&sdor=fda.gov\"></script> \r\n<script type=\"text/javascript\">\r\n   var _U = \"undefined\";\r\n   var g_HttpRelativeWebRoot = \"/ucm/\";\r\n   var SSContributor = false;\r\n   var SSForceContributor = false;\r\n   var SSHideContributorUI = false;\r\n   var ssUrlPrefix = \"/\";\r\n   var ssUrlType = \"1\";\r\n   \r\n   var g_navNode_Path = new Array();\r\n   g_navNode_Path[0] = '1201';\r\n   g_navNode_Path[1] = '1841';\r\n   g_navNode_Path[2] = '2112';\r\n   g_navNode_Path[3] = '2126';\r\n   g_navNode_Path[4] = '4983';\r\n   \r\n   var g_ssSourceNodeId = \"4983\";\r\n   var g_ssSourceSiteId = \"FDAgov\";\r\n   var g_strLanguageId = \"en\";\r\n</script>\r\n<!--<script id=\"SSNavigationFunctionsScript\" type=\"text/javascript\" src=\"/ucm/websites/FDAgov/sitenavigationfunctions.js\"></script>\r\n<script id=\"SSNavigationScript\" type=\"text/javascript\" src=\"/ucm/websites/FDAgov/sitenavigation.js\"></script>-->\r\n\r\n\t<script type=\"text/javascript\" src=\"/ucm/resources/wcm/sitestudio/wcm.toggle.js\"></script>\r\n\t<script type=\"text/javascript\" src=\"/ucm/resources/sitestudio/ssajax/ssajax.js\"></script>\r\n\t\t\r\n\r\n</head>\r\n<!--[if IE 8]> <body class=\"no-js lt-ie9\"> <![endif]-->\r\n<!--[if IE 9]> <body class=\"no-js lt-ie10\"> <![endif]-->\r\n<!--[if gt IE 9]><!--> <body> <!--<![endif]-->\r\n\t\t\t\r\n\t\t\r\n\t\r\n\t<div class=\"quicklinks\"> \r\n  <a href=\"#main\" accesskey=\"2\" class=\"quicklinks\" tabindex=\"1\" title=\"Skip to content\">Quick Links: Skip to main page content</a>\r\n  <a href=\"#search-form\" class=\"quicklinks\" tabindex=\"1\" title=\"Skip to search\">Skip to Search</a>\r\n  <a href=\"#fda-topmenu-home\" class=\"quicklinks\" tabindex=\"1\" title=\"Skip to FDA top menu\">Skip to Topics Menu</a>\r\n\t<a href=\"#section-menu\" class=\"quicklinks\" tabindex=\"1\" title=\"Skip to Section table of contents\">Skip to Section Content Menu</a>\r\n<a href=\"#footer-heading\" class=\"quicklinks\" tabindex=\"1\" title=\"Skip to site options\">Skip to Common Links</a>\r\n</div>\r\n\r\n<!--==== BEGIN PAGE OUTER WRAPPER ==== --> \r\n\t<div id=\"outerwrapper\">\r\n\t\t\t<!-- #** VALIDATION not sure what this tag is, but it will fail XHTML validation **# -->\r\n\t\t\t<MAXAMINEIGNORE XMLNS=\"FDA\">\r\n\t\t\t<div id=\"hhs-masthead\">\r\n\t\t\t\t<!--googleoff: index-->\r\n\t\t\t\t<!-- ==== BEGIN RIGHT HHS MASTHEAD ==== -->\r\n\t\t\t\t<div id=\"hhs-rightmast\">\r\n\t\t\t\t\t<!-- ## ADD page-tools ## -->\r\n\t\t\t\t\t<div id=\"page-tools\">\r\n\t\t\t\t\t\t<ul class=\"list-horizontal\">\r\n\t\t\t\t\t\t\t<li><a id=\"font-size-decrease\" href=\"#\" title=\"Decrease font size\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_font_adj_small.png\" alt=\"Decrease font size\" title=\"Decrease font size\"/></a></li>\r\n\t\t\t\t\t\t\t<li><a id=\"font-size-standard\" href=\"#\" title=\"Return font size to normal\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_font_adj_medium.png\" alt=\"Return font size to normal\" title=\"Return font size to normal\"/></a></li>\r\n\t\t\t\t\t\t\t<li><a id=\"font-size-increase\" href=\"#\" title=\"Increase font size\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_font_adj_large.png\" alt=\"Increase font size\" title=\"Increase font size\"/></a></li>\r\n\t\t\t\t\t\t</ul>\r\n\t\t\t\t\t</div>\r\n\t\t\t\t\t<!-- ## END page-tools ## -->\r\n\t\t\t\t</div>\r\n\t\t\t\t<!-- ==== END RIGHT HHS MASTHEAD ==== -->\r\n\t\t\t\t<!-- ==== BEGIN LEFT HHS MASTHEAD ==== -->\r\n\t\t\t\t<div id=\"hhs-leftmast\">\r\n\t\t\t\t\t<a href=\"http://www.hhs.gov/\" title=\"U.S. Department of Health and Human Services\"><img id=\"rrimg1\" border=\"0\" src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_hhs_masthead_logo_r.png\" alt=\"U.S. Department of Health and Human Services\" title=\"U.S. Department of Health and Human Services\"/></a>\r\n\t\t\t\t</div>\r\n\t\t\t\t<!-- ==== END LEFT HHS MASTHEAD ==== -->\r\n\t\t\t</div>\r\n\t\t\t</MAXAMINEIGNORE>\r\n\t\t\t<div id=\"wrapper\">\r\n\t\t\t\t<!-- ==== BEGIN PAGE HEADER ==== -->\r\n\t\t\t\t<div id=\"header\">\r\n\t\t\t\t\t<!-- ==== BEGIN MASTHEAD ==== -->\r\n\t\t\t\t\t<MAXAMINEIGNORE XMLNS=\"FDA\">\r\n\t\t\t\t\t<div id=\"fda-masthead\">\r\n\t\t\t\t\t\t<!-- ==== BEGIN LEFT MASTHEAD ==== -->\r\n\t\t\t\t\t\t<div id=\"fda-leftmast\">\r\n\t\t\t\t\t\t\t<div id=\"FDAlogo\">\r\n\t\t\t\t\t\t\t\t<a href=\"/default.htm\" title=\"FDA, U.S. Food and Drug Administration\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/gov-fda-new-white-png.png\" alt=\"FDA, U.S. Food and Drug Administration\" border=\"0\" title=\"FDA, U.S. Food and Drug Administration\"/></a>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t<!-- ## ADDED print-pagetitle This is what is displayed when the page is printed, rather than the logo ## -->\r\n\t\t\t\t\t\t\t<div class=\"print-pagetitle\">\r\n\t\t\t\t\t\t\t\tU.S. Food &amp; Drug Administration\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t<!-- ## END print-pagetitle ## -->\r\n\t\t\t\t\t\t\t<div class=\"clearfloat\">&nbsp;</div>\r\n\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t<!-- ==== END LEFT FDA MASTHEAD ==== -->\r\n\t\t\t\t\t\t<!-- ==== BEGIN RIGHT MASTHEAD ==== -->\r\n\t\t\t\t\t\t<div id=\"fda-rightmast\">\r\n\t\t\t\t\t\t\t<!-- ## ADDED masthead-links ## -->\r\n\t\t\t\t\t\t\t<div id=\"masthead-links\">\r\n\t\t\t\t\t\t\t\t<ul class=\"list-horizontal\">\r\n\t\t\t\t\t\t\t\t\t<li class=\"first\"><a href=\"/SiteIndex/default.htm\" title=\"A to Z Index\">A to Z Index</a></li>\r\n\t\t\t\t\t\t\t\t\t<li><a href=\"/NewsEvents/InteractiveMedia/default.htm\" title=\"Follow FDA\">Follow FDA</a></li>\r\n\t\t\t\t\t\t\t\t\t<li class=\"last\"><a href=\"/AboutFDA/EnEspanol/default.htm\" title=\"En Espa\u00f1ol\">En Espa\u00f1ol</a></li>\r\n\t\t\t\t\t\t\t\t</ul>\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t<!-- ## END masthead-links ## -->\r\n\t\t\t\t\t\t\t<div id=\"search-form\">\r\n\t\t\t\t\t\t\t\t<form action=\"http://google2.fda.gov/search\" method=\"get\" name=\"searchForm\" id=\"searchbox\">\r\n\t\t\t\t\t\t\t\t\t<label class=\"searchlable\" for=\"search\">Enter Search terms</label>\r\n\t\t\t\t\t\t\t\t\t<input accesskey=\"4\" id=\"search\" type=\"text\" name=\"q\" onKeyUp=\"getRequest()\" autocomplete=\"off\" />\r\n\t\t\t\t\t\t\t\t\t<!-- ## ADDED go_button ## -->\r\n\t\t\t\t\t\t\t\t\t<div id=\"go_button\">\r\n\t\t\t\t\t\t\t\t\t\t<a href=\"javascript:document.getElementById('searchbox').submit();\" title=\"Search this site\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_mast_search_button.png\" alt=\"Search\" title=\"Search this site\"/></a>\r\n\t\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\t<!-- ## END go_button -->\r\n<div id=\":0D\" class=\"ac-renderer ss-gac-m\" role=\"listbox\" style=\"margin-top:-21px; background-color: #ffffff; min-width: 204px; width: 100%; top: 0 !important; position:relative !important; left:0 !important; -moz-user-select: none; display: none;\"></div>                                     \r\n\t\t\t\t\t\t\t\t\t<!-- ==== BEGIN HIDDEN SEARCH FIELDS ==== -->\r\n\t\t\t\t\t\t\t\t\t<input type=\"hidden\" name=\"client\" value=\"FDAgov\" />\r\n\t\t\t\t\t\t\t\t\t<input type=\"hidden\" name=\"site\" value=\"FDAgov\" />\r\n\t\t\t\t\t\t\t\t\t<input type=\"hidden\" name=\"lr\" value=\"\" />\r\n\t\t\t\t\t\t\t\t\t<input type=\"hidden\" name=\"proxystylesheet\" value=\"FDAgov\" />\r\n\t\t\t\t\t\t\t\t\t<input type=\"hidden\" name=\"requiredfields\" value=\"-archive:Yes\" />\r\n\t\t\t\t\t\t\t\t\t<input type=\"hidden\" name=\"output\" value=\"xml_no_dtd\"/>\r\n\t\t\t\t\t\t\t\t\t<input type=\"hidden\" name=\"getfields\" value=\"*\" />\r\n\t\t\t\t\t\t\t\t\t<!-- ==== END HIDDEN SEARCH FIELDS ==== -->\r\n\t\t\t\t\t\t\t\t</form>\r\n\t\t\t\t\t\t\t\t<div class=\"clearfloat\">&nbsp;</div>\r\n\t\t\t\t\t\t\t</div>\r\n\r\n\r\n\t\t\t\t\t\t</div> \r\n\t\t\t\t\t\t<div class=\"clearfloat\">&nbsp;</div>\r\n\t\t\t\t\t\t<!-- ==== END RIGHT MASTHEAD ==== -->\r\n\t\t\t\t\t</div>\r\n\t\t\t\t\t</MAXAMINEIGNORE>\r\n\r\n\r\n<div id=\"fda-topmenu\">\r\n            <ul class=\"menu-tabbed\">\r\n                  <li><a title=\"Home\" href=\"/default.htm\" id=\"fda-topmenu-home\" accesskey=\"1\"><span>Home</span></a></li>\r\n                  <li><a title=\"Food\" href=\"/Food/default.htm\"><span>Food</span></a></li>\r\n                  <li><a title=\"Drugs\" href=\"/Drugs/default.htm\"><span>Drugs</span></a></li>\r\n                  <li><a title=\"Medical Devices\" href=\"/MedicalDevices/default.htm\"><span>Medical Devices</span></a></li>\r\n                  <li><a title=\"Radiation-Emitting Products\" href=\"/Radiation-EmittingProducts/default.htm\"><span>Radiation-Emitting Products</span></a></li>\r\n                  <li><a title=\"Vaccines, Blood and Biologics\" href=\"/BiologicsBloodVaccines/default.htm\"><span>Vaccines, Blood & Biologics</span></a></li>\r\n                  <li><a title=\"Animal and Veterinary\" href=\"/AnimalVeterinary/default.htm\"><span>Animal & Veterinary</span></a></li>\r\n                  <li><a title=\"Cosmetics\" href=\"/Cosmetics/default.htm\"><span>Cosmetics</span></a></li>\r\n                  <li><a title=\"Tobacco Products\" href=\"/TobaccoProducts/default.htm\"><span>Tobacco Products</span></a></li>\r\n            </ul>\r\n    </div>\r\n<div class=\"clearfloat\">&nbsp;</div>\r\n\t\t\t</div>\r\n\t\t\t<!--googleon: index-->\r\n\r\n\t<div id=\"content\">\r\n\t\t  <div class=\"clearfloat\"> </div>\r\n\t\t  <div class=\"clearfloat\"> </div>\r\n\t<!--==== BEGIN Topic Page Title ==== -->\r\n\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t<h2 id=\"topic_page_title\" class=\"head1\">Inspections, Compliance, Enforcement, and Criminal Investigations</h2>\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t<!--==== END Topic Page Title ==== -->\r\n\t\t\t\t\t<!-- ## ADD page-options ## -->\r\n\t\t\t\t\t<div id=\"page-options\" class=\"hover-fade\">\r\n\t\t\t\t\t\t<ul class=\"list-horizontal\">\r\n\t\t\t\t\t\t\t<li><a href=\"javascript:window.print();\" title=\"Print this page\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_utility_icon_print.png\" alt=\"Print\"  title=\"Print this page\"/></a></li>\r\n\t\t\t\t\t\t\t<li><a href=\"http://www.addthis.com/bookmark.php?u508=true&v=152&amp;username=fdamain\" class=\"addthis_button_compact\" title=\"Share this page\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_utility_icon_share.png\" alt=\"Share\" title=\"Share this page\"/></a></li>\r\n\t\t\t\t\t\t\t<li><a href=\"http://www.addthis.com/bookmark.php\" class=\"addthis_button_email\" title=\"E-mail this page\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_utility_icon_email.png\" alt=\"E-mail\" title=\"E-mail this page\"/></a></li>\r\n\t\t\t\t\t\t\t<!-- END enEspanol Button -->\r\n\t\t\t\t\t\t</ul>\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t<script type=\"text/javascript\" src=\"http://s7.addthis.com/js/250/addthis_widget.js#pub=fdamain\"></script>\r\n\r\n\t\t<script type=\"text/javascript\">var addthis_config = {data_track_clickback: true, ui_508_compliant: true, services_compact: 'facebook, twitter, linkedin, pinterest_share,  email', services_exclude: 'print', image_container: \"#content\" } ;</script>\r\n\t\t\t\t\t</div>\r\n\t\t\t\t\t<!-- ## END page-options ## -->\r\n\t<!--==== BEGIN Breadcrumbs  non-mobile breadcrumb:FDAgov:4983:nonmobile==== -->\r\n\t\r\n<div id=\"fda-breadcrumbs\" class=\"fda-breadcrumbs\">\r\n<!-- Check if Node List exists and user is not at the homepage.  If the user is at the homepage, hide the breadcrumb -->\r\n<!-- Limits Level of BreadCrumb to 4 -->\r\n<div class=\"hmenu\">\r\n\t\t<ul class=\"list-horizontal contentpage\">\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t\t<li><a href = \"/default.htm\" >Home</a></li>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t\t<li><a href = \"/ICECI/default.htm\" >Inspections, Compliance, Enforcement, and Criminal Investigations</a></li>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t\t<li><a href = \"/ICECI/EnforcementActions/default.htm\" >Compliance Actions and Activities</a></li>\r\n\t\t\t\r\n\t\t\t\t <!-- check if second last item in NodeList -->\r\n\t\t\t\t\t<li class=\"secondLast\"><a href = \"/ICECI/EnforcementActions/WarningLetters/default.htm\" id = \"main\">Warning Letters</a></li>\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t <!-- check if last item in NodeList -->\r\n\t\t\t\t\t<li class=\"last\"><a href = \"/ICECI/EnforcementActions/WarningLetters/2013/default.htm\" >2013</a></li>\r\n\t</ul>\r\n</div>\r\n</div>\r\n\r\n\r\n\r\n\t<!--==== END Breadcrumbs ==== --> \r\n\r\n\t\t<!--showWideScreenFormat=-->\r\n\t<div class=\"left-column\">\r\n\t\t\t\r\n<!-- Wrapping Style Div -->\r\n\t<div id=\"main_left_nav\">\r\n\t<div class=\"liquid-round\">\r\n\t<div class=\"top\"><span></span></div>\r\n\t<div class=\"liquid-round-header\">\r\n\r\n\t</div>\r\n\t<div class=\"center-content\" id=\"section-menu\">\r\n\t<h2 class=\"searchlable\">Section Contents Menu</h2>\r\n\t\r\n\t\r\n\t\t\t\t<p class=\"header_bg\"><strong><a href=\"/ICECI/EnforcementActions/default.htm\">Compliance Actions and Activities</a></strong></p>\r\n\t\t        \t\r\n\t\t\t\t\t \r\n\t\t\t\t\t\t\t<ul id=\"tabMenu\" class=\"leftnav_child\"><li class=\"leftnav_parent\"><a href=\"/ICECI/EnforcementActions/WarningLetters/default.htm\">Warning Letters</a></li></ul>\r\n\t\t\t\t\t \r\n\t\t\t\t\t\t\t<ul id=\"tabMenu\" class=\"leftnav_child\"><li id=\"left_nav_4983\" class=\"leftnav_current\"><a href=\"/ICECI/EnforcementActions/WarningLetters/2013/default.htm\">2013</a></li></ul>\r\n\t<!-- Subsection links -->\r\n\t\r\n\t\t\t<ul id=\"tabMenu\" class=\"leftnav_child\">\r\n\t</ul>\r\n\r\n</div> <!--- center-content -->\r\n<div class=\"bottom\"><span></span></div>\r\n</div> <!-- liquid-round -->\r\n</div>\r\n\r\n<!--BEGIN Resources_for_You Box -->\r\n    \r\n \r\n<script type=\"text/javascript\">\r\nvar maincontentcss = document.getElementById(\"middle_js\");\r\nif(maincontentcss)\r\n{\r\n\tmaincontentcss.style.width = \"71%\";\r\n}\r\n</script>\r\n\r\n<!--END Resources_for_You Box -->\r\n\t<div class=\"clearfloat\"> </div>\r\n\t</div>\r\n\t<div class=\"middle-column\">\r\n\t<a name=\"main\"></a>\r\n\t\t<h1 class=\"head1_body\">Altasource LLC DBA Metalabs LLC 2/25/13</h1>\r\n\t\t\r\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"0\" width=\"98%\"><tbody><tr><td valign=\"middle\">&nbsp;</td><td valign=\"bottom\">&nbsp;</td></tr><tr><td height=\"63\" valign=\"middle\" width=\"67%\"><h3 style=\"text-align: left; background-color: #ffffff; color: #000080; font-size: 0.8em; font-weight: bold\"><img border=\"0\" alt=\"Department of Health and Human Services logo\" src=\"/ucm/groups/fdagov-public/documents/image/ucm113123.gif\" />Department of Health and Human Services</h3></td><td valign=\"bottom\" width=\"33%\">Public Health Service<br />Food and Drug Administration</td></tr><tr><td valign=\"middle\">&nbsp;</td><td valign=\"top\">Atlanta District Office<br />60 8th St., NE<br />Atlanta, GA 30309&nbsp;</td></tr></tbody></table><p>&nbsp;</p><div align=\"center\">February 25, 2013</div><div align=\"center\">&nbsp;</div><div align=\"center\">&nbsp;</div><div><b>VIA UPS</b><b>&nbsp;</b></div><div>&nbsp;</div><div>Bassam Khayat, Owner</div><div>Altasource, LLC d/b/a Meta Labs LLC</div><div>1009 Mansell Rd., Suite L</div><div>Roswell, GA 30076-4816</div><div>&nbsp;</div><div align=\"center\"><b>WARNING LETTER</b></div><div align=\"center\"><b>(13-ATL-11)</b></div><div align=\"center\"><b>&nbsp;</b></div><div>Dear Mr. Khayat:</div><div>&nbsp;</div><div>On July 17-20, 2012, the U.S. Food &amp; Drug Administration (FDA) conducted an inspection of your dietary supplement and cosmetic manufacturing and distribution facility located at 1009 Mansell Rd., Suite L, Roswell, GA.&nbsp;The inspection revealed serious violations of the Current Good Manufacturing Practice (CGMP) regulations for dietary supplements in Title 21 of the Code of Federal Regulations, Part 111 (21 CFR Part 111).&nbsp;These CGMP violations cause your dietary supplement products to be adulterated under section 402(g)(1) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 United States Code (U.S.C.) &sect;&nbsp;342(g)(1)], in that the dietary supplements were prepared, packed, or held under conditions that do not meet the CGMP regulations for dietary supplements.&nbsp;Our investigator&rsquo;s observations were noted on Form FDA-483, entitled &ldquo;Inspectional Observations,&rdquo; which was issued to you at the close of the inspection.&nbsp;</div><div>&nbsp;</div><div>In addition, we have reviewed the labeling of your products collected at the inspection and your website located at the Internet address www.metalabsllc.com<span> and have determined that two of your products marketed as dietary supplements, &ldquo;Respiratory Response&rdquo; and &ldquo;African Mango,&rdquo; as well as two of your topical products, &ldquo;Coffee Black Salve&rdquo; and &ldquo;Meta-Cell,&rdquo; are promoted for conditions that cause the products to be drugs under section 201(g)(1)(B) of the Act [21 U.S.C. &sect;&nbsp;321(g)(1)(B)]. The therapeutic claims on the labeling for these products establish that the products are drugs because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. The marketing of these products with these claims violates the Act. Further, your &ldquo;Red Yeast Rice with CoQ-10&rdquo; and &ldquo;Conjugated Linoleic Acid&rdquo; products are misbranded under section 403 of the Act [21 U.S.C. &sect; 343] and the regulations implementing the food labeling requirements of the Act, which are found in 21 CFR Part 101. &nbsp;Additionally, even if your &ldquo;Respiratory Response&rdquo; and &ldquo;African Mango&rdquo; products, which are marketed as dietary supplements, were not drugs under section 201(g)(1)(B) of the Act [21 U.S.C. &sect; 321(g)(1)(B)], they would be misbranded under section 403 of the Act [21 U.S.C. &sect; 343] and the regulations implementing the food labeling requirements of the Act, found in 21 CFR Part 101.&nbsp;You can find the Act and FDA regulations through links on FDA&rsquo;s home page at www.fda.gov.</span></div><div><b>&nbsp;</b></div><div><b>Unapproved New Drugs</b></div><div>&nbsp;</div><div>Examples of some of the claims that cause your &ldquo;Respiratory Response,&rdquo; &ldquo;African Mango,&rdquo; &ldquo;Coffee Black Salve,&rdquo; and &ldquo;Meta-Cell&rdquo; products to be drugs as defined in section 201(g)(1)(B) of the Act [21 U.S.C. &sect; 321(g)(1)(B)] include, but are not limited to, the following:</div><div>&nbsp;</div><div><b>Products Marketed as Dietary Supplements</b></div><div>&nbsp;</div><div><b><span>&ldquo;Respiratory Response&rdquo;:</span></b></div><div>&nbsp;</div><ul><li>&ldquo;Relief from Allergies, Asthma&rdquo;</li><li>&ldquo;May also clear mucous and phlegm from allergens &hellip; or colds &amp; flu that restrict normal breathing&rdquo;</li><li>&ldquo;[D]eveloped to fight &hellip; shortness of breath and congestion from asthma, exercise induced asthma, emphysema, allergies, bronchitis, colds, and flu.&rdquo;</li><li>&ldquo;Traditionally used to treat airway constriction due to asthma and other respiratory conditions.&rdquo;</li><li>&ldquo;Active ingredients:&rdquo;</li></ul><div style=\"margin-left: 80px\"><span>o<span>&nbsp;&nbsp; </span></span>&ldquo;Tylophora:&nbsp;Traditionally used to treat airway constriction due to asthma and other respiratory conditions.&rdquo;</div><div style=\"margin-left: 80px\"><span>o<span>&nbsp;&nbsp; </span></span>&ldquo;Codonopsis Pilosula:&nbsp;... fights viral infections, coughs, and other respiratory conditions.&rdquo;</div><div style=\"margin-left: 80px\"><span>o<span>&nbsp;&nbsp; </span></span>&ldquo;Ginger: Uses include treating upper respiratory tract infections&hellip;bronchitis.&rdquo;</div><div><b><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></b></div><div><b>&ldquo;African Mango&rdquo;:</b></div><div><b>&nbsp;</b></div><ul><li>&ldquo;[I]t&rsquo;s highly effective in sequestering cholesterol and taking it out of your body.&rdquo;</li><li>&ldquo;According to the Global In statute <i>[sic]</i> for Bioexploration, extract of the dikanut may help to alleviate diarrhea, diabetes, hernia and yellow fever&rdquo;</li><li>&ldquo;Clinical studies also support the pit of African mango as a treatment aid for obesity and elevated levels of low-density lipoprotein, or LDL cholesterol.&rdquo;</li><li>&ldquo;Albert Ayena, Ph.D&hellip;.states that the oil contained in the fruit&rsquo;s seed is abundant in beta carotene. National Institutes of Health explains that beta carotene is effective at preventing certain cancers, high blood pressure, infertility, heartburn and some emotional and mental disorders.&rdquo;</li></ul><div>&nbsp;</div><div><b>Topical Products</b></div><div>&nbsp;</div><div><b><span>&nbsp;&ldquo;Coffee Black Salve,&rdquo; which contains &ldquo;caffeine extract&rdquo; according to its label:</span></b></div><div>&nbsp;</div><ul><li>&ldquo;Can Coffee Fight Skin Cancer? READ OUR BROCHURE FOR MORE INFORMATION. With Coffee Black Salve you might have the help that you need to fight Skin Blemish and Skin Cancer&rdquo;</li><li>&ldquo;Our research showed that&hellip;a special cream formula, performed beyond expectations in reducing Skin Blemish and Skin Cancer.&rdquo;</li><li>&ldquo;[C]affeine acts selectively, causing the abnormal skin cells to die but not affecting the normal cells.&rdquo;</li><li>&ldquo;Can Coffee Fight Skin Cancer? Skin cancer is the most common of all cancers&hellip;Generally skin cancer is curable by cutting, burning, or freezing the tumor cells but, if left untreated, it can be deadly. With Coffee Black Salve you might have the help that you need to fight Skin Blemishes and Skin Cancer!&rdquo;</li><li>&ldquo;Coffee Black Salve&rsquo;s caffeine cancer protection occurs inside the skin cells after exposure to the ultraviolet rays.&nbsp;We had a 50 to 70 percent inhibition of tumor formation in the mice that were treated with caffeine or EGCG (the chemical compound)&rdquo;</li><li>&ldquo;[C]affeine apparently blocks the growth and development of abnormal cells by causing them to kill themselves, a type of programmed cell suicide that prevents development of abnormal growths. . . . . [T]he caffeine acts selectively, causing the abnormal skin cells to die but does not affect the healthy, normal cells.&rdquo;</li></ul><div><b>&nbsp;</b></div><div><b><span>&ldquo;Meta-Cell,&rdquo; which contains &ldquo;Glutathione Reduced&rdquo; according to its label:</span></b></div><div><b><span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></b></div><ul><li>&ldquo;A combination that can help your body repair damage caused by &hellip;radiation, disease, infections, drugs, &hellip; aging, injury, trauma, and burns? Well, Meta-Cell Cream&hellip;has been specially created by Meta Labs just for that purpose!&rdquo;</li><li>&ldquo;The best studies of Glutathione have been conducted in cancer patients. One study involved women with ovarian cancer who were being treated with chemotherapy... Those given the Glutathione not only had fewer side effects from the chemotherapy but also had better overall survival rates.&rdquo;</li></ul><div>&nbsp;</div><div>Your products identified above are not generally recognized as safe and effective for the above-referenced uses and, therefore, the products are &ldquo;new drugs&rdquo; under section 201(p) of the Act [21 U.S.C. &sect; 321(p)]. New drugs may not be legally marketed in the U.S. without prior approval from FDA as described in section 505(a) of the Act [21 U.S.C. &sect; 355(a)]. FDA approves a new drug on the basis of scientific data submitted by a drug sponsor to demonstrate that the drug is safe and effective.</div><div>&nbsp;</div><div>Furthermore, your &ldquo;Respiratory Response,&rdquo; &ldquo;African Mango,&rdquo; &ldquo;Coffee Black Salve,&rdquo; and &ldquo;Meta-Cell&rdquo; products are offered for conditions that are not amenable to self-diagnosis and treatment by individuals who are not medical practitioners. Therefore, adequate directions for use cannot be written so that a layperson can use these drugs safely for their intended purposes.&nbsp;&nbsp;Thus, these products are misbranded under section 502(f)(1) of the Act [21 U.S.C. &sect; 352(f)(1)], in that the labeling for these drugs fails to bear adequate directions for their intended uses. &nbsp;Because your &ldquo;Respiratory Response,&rdquo; &ldquo;African Mango,&rdquo; &ldquo;Coffee Black Salve,&rdquo; and &ldquo;Meta-Cell&rdquo; products lack required approved applications, they are not exempt under 21 CFR 201.100(c)(2) and&nbsp;201.115 from the requirements of section 502(f)(1) of the Act.&nbsp;The introduction or delivery for introduction into interstate commerce of &ldquo;Respiratory Response,&rdquo; &ldquo;African Mango,&rdquo; &ldquo;Coffee Black Salve,&rdquo; and &ldquo;Meta-Cell&rdquo; violates section 301(a) of the Act [21 U.S.C. &sect; 331(a)].<span>&nbsp;&nbsp;&nbsp; </span></div><div>&nbsp;</div><div><b>Adulterated Dietary Supplements</b></div><div><b>&nbsp;</b></div><div>The inspection revealed the following significant violations of the CGMP requirements for dietary supplements.&nbsp;These violations cause your dietary supplement products to be adulterated under section 402(g)(1) of the Act [21 U.S.C. &sect; 342(g)(1)].&nbsp;Also note that, even if your &ldquo;Respiratory Response&rdquo; and &ldquo;African Mango&rdquo; products were not unapproved new drugs under section 505(a) of the Act [21 U.S.C. &sect; 355(a)], as dietary supplements they would be adulterated under section 402(g)(1) of the Act [21 U.S.C. &sect; 342(g)(1)].</div><div>&nbsp;</div><div><span>1.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>You failed to make and keep written procedures for the responsibilities of the quality control operations, including written procedures for conducting a material review and making a disposition decision and written procedures for approving or rejecting any reprocessing, to comply with 21 CFR 111.140(b)(1). Specifically, you have failed to establish any such written procedures for responsibilities pertaining to the quality control operations, including, but not limited to, reviewing the manufacturing, packaging, labeling, and holding operations for making disposition decisions. You have no procedures for reviewing and approving laboratory control systems, ensuring that any required tests are conducted, or reviewing results of tests and examinations.</div><div>&nbsp;</div><div><span>2.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>You failed to establish and follow written procedures for returned dietary supplement, and you failed to identify and quarantine returned dietary supplement until quality control personnel conduct a material review and make a disposition decision, to comply with 21 CFR 111.503 and 21 CFR 111.510, respectively. Specifically, you stated that you received returned dietary supplement and redistributed the product on several occasions without documenting whether or how the product was evaluated prior to redistribution. Furthermore, you stated that if the product does not look adulterated, is sealed, and is within the expiration date, then it is redistributed, without any indication of quality control review.</div><div>&nbsp;</div><div><span>3.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>You failed to prepare and follow a written master manufacturing record (MMR) for each unique formulation of dietary supplement that you manufacture, and for each batch size, to ensure uniformity in the finished batch from batch to batch, to comply with 21 CFR 111.205(a). Specifically, you indicated during the inspection that you actively manufacture approximately&nbsp;<strong>(b)(4)</strong> dietary supplements; however, you stated that you did not prepare an MMR for any of the dietary supplements you have manufactured. For example, your firm manufactured Meta-Gen Red Yeast Rice with CoQ-10 lot number F141201, but you failed to prepare or follow a written MMR for this dietary supplement. You must prepare and follow an MMR for all dietary supplement products that you manufacture that meet the requirements specified in 21 CFR 111.210.</div><div>&nbsp;</div><div><span>4.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>You failed to make and keep records documenting why the results of appropriate tests or examinations for the product specifications selected under 111.75(c)(1) ensure that the dietary supplement meets all product specifications, to comply with 21 CFR 111.95(b)(4). You stated during the inspection that you conduct a visual examination of your finished products to check if they are mixed properly, and that you check the specific gravity and examine capsules, product weight, shape, formation, and taste. However, you did not provide written procedures or documentation that any of these tests and examinations was conducted. Furthermore, you failed to provide adequate documentation of your basis for determining that compliance with the stated specifications would ensure that your finished batch of the dietary supplement meets all product specifications for identity, purity, strength, and composition, and the limits on those types of contamination that may adulterate, or that may lead to the adulteration of the dietary supplement, in accordance with 21 CFR 111.75(c)(3). &nbsp;&nbsp;</div><div>&nbsp;</div><div><span>5.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>You failed to prepare a batch production record every time you manufacture a batch of dietary supplements to comply with 21 CFR 111.255(a).&nbsp;Specifically, you stated during the inspection that you do not have batch records for any of the dietary supplements that you have manufactured. You must create batch production records that include all elements of 21 CFR 111.260.</div><div>&nbsp;</div><div><span>6.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>You failed to establish laboratory control processes that are reviewed and approved by quality control personnel, including the use of criteria for selecting standard reference materials used in performing tests and examinations to comply with 21 CFR 111.315(d). Specifically, you stated during the inspection that you compare the results of your tests and examinations to the previous lots or samples of the ingredient. However, you failed to use any criteria to establish a reference standard. Reference standards should be of the highest purity by reasonable effort and should be thoroughly characterized to ensure their identity, purity, quality, and strength.</div><div>&nbsp;</div><div><span>7.<span>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>You must make and keep records of the written procedures for manufacturing operations to comply with 21 CFR 111.375(b).&nbsp;You must also establish and follow written procedures for manufacturing operations to comply with 21 CFR 111.353. Your firm does not have any such written procedures for manufacturing operations.&nbsp;Such records are required to ensure your dietary supplements are manufactured in a manner that ensures product specifications are consistently met.</div><div>&nbsp;</div><div><b>Misbranded Dietary Supplements</b></div><div>&nbsp;</div><div>Your &ldquo;Conjugated Linoleic Acid&rdquo; and &ldquo;Red Yeast Rice with CoQ-10&rdquo; dietary supplements are misbranded under section 403 of the Act [21 U.S.C. &sect; 343], as follows:</div><div>&nbsp;</div><ol type=\"1\"><li>Your &ldquo;Conjugated Linoleic Acid&rdquo; product is misbranded under section 403(i)(2) of the Act [21 U.S.C. &sect; 343(i)(2)] because the product is made from two or more ingredients and the label fails to declare each ingredient by its common or usual name, as required by 21 CFR 101.4. &ldquo;Cis-9 Trans-11 isomer&rdquo; and &ldquo;Trans-10 Cis-12 Isomer&rdquo; are not common or usual names for ingredients; both names are incomplete because they fail to identify the specific compounds in the dietary supplement.</li></ol><ol type=\"1\" start=\"2\"><li>Your &ldquo;Red Yeast Rice with CoQ-10&rdquo; and &ldquo;Conjugated Linoleic Acid&rdquo; products are misbranded under section 403(q)(5)(F) of the Act [21 U.S.C. &sect;&nbsp;343(q)(5)(F)] because the nutrition information on their labels is not provided in the format specified in FDA&rsquo;s regulations. For example, &ldquo;other ingredients&rdquo; (those that are not dietary ingredients) in a dietary supplement must be listed outside the Supplement Facts panel [21 CFR 101.4(g); see 21 CFR 101.36(e)].&nbsp;&nbsp;</li><li>Your &ldquo;Conjugated Linoleic Acid&rdquo; product is misbranded under section 403(a)(1) because the label states that your product has 90 softgels; however, the serving size is listed as 2 capsules, and the number of servings per container is listed as 125. &nbsp;One or more of these label statements is false and misleading.&nbsp;</li></ol><div>&nbsp;</div><div>Additionally, even if the labeling for your &ldquo;Respiratory Response&rdquo; and &ldquo;African Mango&rdquo; products did not contain claims that cause them to be unapproved new drugs, as dietary supplements they would be misbranded under section 403 of the Act [21 U.S.C. &sect;&nbsp;343] for the following reasons:&nbsp;</div><div>&nbsp;</div><ol type=\"1\"><li>The label of your &ldquo;Respiratory Response&rdquo; lists the dietary ingredient &ldquo;Prince Ginseng (Pseudostellaria heterophylla) root&rdquo; in the Supplement Facts panel. Under section 403(u) of the Act [21 U.S.C. &sect;&nbsp;343(u)], a dietary supplement or other food is misbranded if it is represented as ginseng but is not derived from a plant classified within the genus Panax.</li></ol><ol type=\"1\" start=\"2\"><li>The labels of your &ldquo;Respiratory Response&rdquo; and &ldquo;African Mango&rdquo; products list the &ldquo;other ingredients&rdquo; in these products within the Supplement Facts panel.&nbsp;Under section 403(q)(5)(F) of the Act [21 U.S.C. &sect; 343(q)(5)(F)], a food is misbranded unless it bears nutrition information in the format specified in FDA&rsquo;s regulations, which require &ldquo;other ingredients&rdquo; to be declared outside the Supplement Facts panel, separate from nutrition information about dietary ingredients [21 CFR 101.4(g); see 21 CFR 101.36(e)].</li></ol><div>&nbsp;</div><div>This letter is not intended to be an all-inclusive list of the violations that may exist at your facility. <span>&nbsp;&nbsp;You are responsible for investigating and determining the causes of the violations identified above and for preventing their recurrence or the occurrence of other violations.&nbsp;It is your responsibility to ensure that your firm complies with all requirements of federal law and FDA regulations. </span></div><div>&nbsp;</div><div>You should take prompt action to correct the violations cited in this letter.&nbsp;Failure to promptly correct these violations may result in legal action, such as seizure or injunction, without further notice.&nbsp;</div><div>&nbsp;</div><div>Within 15 working days from your receipt of this letter, please notify this office in writing of the specific steps you have taken to correct violations.&nbsp;Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation.&nbsp;If you are unable to complete corrective action within 15 working days, state the reason for the delay and the time within which you will complete the correction.</div><div>&nbsp;</div><div>Section 743 of the Act [21 U.S.C. &sect; 379j-31] authorizes FDA to assess and collect fees to cover FDA&rsquo;s costs for certain activities, including reinspection-related costs. A reinspection is one or more inspections conducted subsequent to an inspection that identified noncompliance materially related to a food safety requirement of the Act, specifically to determine whether compliance has been achieved.&nbsp;Reinspection-related costs means all expenses, including administrative expenses incurred in connection with FDA&rsquo;s arranging, conducting, and evaluating the results of the reinspection and assessing and collecting the reinspection fees [21 U.S.C. &sect; 379j-31(a)(2)(B)].&nbsp;For a domestic facility, FDA will assess and collect fees for reinspection-related costs from the responsible party for the domestic facility.&nbsp;The inspection noted in this letter identified noncompliance materially related to a food safety requirement of the Act.&nbsp;Accordingly, FDA may assess fees to cover any reinspection-related costs.&nbsp;</div><div>&nbsp;</div><div>Your written response should be sent to the U.S. Food and Drug Administration, Attn: Janice L. King, Compliance Officer, at the address noted in the letterhead.&nbsp;If you have questions, please contact Mrs. King at 843-746-2990 or write her at the noted address.&nbsp;</div><div>&nbsp;</div><div>&nbsp;</div><div>Sincerely</div><div>/S/</div><div style=\"text-align: left\">John R.Gridley</div><div style=\"text-align: left\">District Director</div><div style=\"text-align: left\">Atlanta District Office</div><div align=\"center\">&nbsp;</div> \r\n      &nbsp;\r\n      <div class=\"clearfloat\">\r\n        -\r\n      </div>\r\n \r\n<!--==== BEGIN Mainlist_Folio ====-->\r\n<div>\r\n</div>\r\n\t\r\n\t\r\n\t\r\n\t\r\n<!--isForRelatedTablesAndLinks=1-->\r\n\r\n \r\n\r\n\t\r\n\t\t  \t     \r\n\t\t \r\n \r\n<script type=\"text/javascript\">\r\nvar maincontentcss = document.getElementById(\"middle_js\");\r\nif(maincontentcss)\r\n{\r\n\tmaincontentcss.style.width = \"71%\";\r\n}\r\n</script>\r\n \r\n\t\t<div class=\"clearfloat\"> </div>\r\n\t\t</div>\r\n\t<div class=\"clearfloat\"> </div>\r\n\r\n\t\t<div class=\"clearfloat\"> </div>\r\n\t\t</div><!--content-->\r\n\t\t  \r\n\t\t<!--==== BEGIN CTP Disclaimer ==== -->\r\n<!--mp_trans_add\r\n<blockquote>\r\n<hr>\r\n<p>This website has been translated to Spanish from English, and is updated often. It is possible that some links will connect you to content only \r\navailable in English or some of the words on the page will appear in English until translation has been completed (usually within 24 hours). We \r\nappreciate your patience with the translation process. In the case of any discrepancy in meaning, the English version is considered official. Thank \r\nyou for visiting <a href=\"http://esp.fda.gov/TobaccoProducts/default.htm\">esp.fda.gov/tabaco.</a></p>\r\n</blockquote>\r\n-->\r\n<!--==== END CTP Disclaimer ==== -->\r\n\r\n\r\n<script type=\"text/javascript\">\r\n\tsetStyle();\r\n</script>\r\n\t\t<!--==== BEGIN FOOTER ==== -->\r\n\t\t\t<!--googleoff: index-->\r\n\t\t\t<div id=\"footer\">\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t<!-- ==== BEGIN Page Tools Bottom ==== -->\r\n\t\t\t\t<div id=\"pagetools_bottom\">\r\n\t\t\t\t<div id=\"pagetools_right\">\r\n\t\t\t\t<p>\r\n\r\n<!-- <ul> -->\r\n\r\n\r\n\t\t\r\n\t\t\r\n\t\r\n\t<!-- <li>Page Last Updated: 09/13/2013</li> -->\r\n\tPage Last Updated: 09/13/2013\r\n<!-- </ul> -->\r\n\r\n\r\n\t<br/>\r\n\tNote: If you need help accessing information in different file formats, see <a href=\"/AboutFDA/AboutThisWebsite/WebsitePolicies/ViewingFiles/default.htm\">Instructions for Downloading Viewers and Players</a>.<br />\r\n   Language Assistance Available: <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#spanish\" title=\"Spanish\">Espa\u00f1ol</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#chinese\" title=\"Chinese\">\u7e41\u9ad4\u4e2d\u6587</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#vietnamese\" title=\"Vietnamese\">Ti\u1ebfng Vi\u1ec7t</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#korean\" title=\"Korean\">\ud55c\uad6d\uc5b4</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#tagalog\" title=\"Tagolog\">Tagalog</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#russian\" title=\"Russian\">\u0420\u0443\u0441\u0441\u043a\u0438\u0439</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#arabic\" title=\"Arabic\">\u0627\u0644\u0639\u0631\u0628\u064a\u0629</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#creole\" title=\"Creole\">Krey\u00f2l Ayisyen</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#french\" title=\"French\">Fran\u00e7ais</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#polish\" title=\"Polish\">Polski</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#portuguese\" title=\"Portuguese\">Portugu\u00eas</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#italian\" title=\"Italian\">Italiano</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#german\" title=\"German\">Deutsch</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#japanese\" title=\"Japanese\">\u65e5\u672c\u8a9e</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#farsi\" title=\"Farsi\">\u0641\u0627\u0631\u0633\u06cc</a> | <a href=\"/AboutFDA/AboutThisWebsite/ucm523741.htm#english\" title=\"English\">English</a>\t\r\n\t\t\t\t</p>\r\n\t\t\t\t</div>\r\n\t\t\t\t<br class=\"clearfloat\" />\r\n\t\t\t\t</div>\r\n\t\t\t\t<!-- ## ADDED footer-heading ## -->\r\n\t\t\t\t<div id=\"footer-heading\">\r\n\t\t\t\t\t<div id=\"footer-fdalinks\">\r\n\t\t\t\t\t\t<ul class=\"list-horizontal\">\r\n\t\t\t\t\t\t\t<li class=\"first\"><a href=\"/AboutFDA/AboutThisWebsite/Accessibility/default.htm\" title=\"Accessibility\">Accessibility</a></li>\r\n\t\t\t\t\t\t\t<li><a href=\"/AboutFDA/ContactFDA/default.htm\" title=\"Contact FDA\">Contact FDA</a></li>\r\n\t\t\t\t\t\t\t<li><a href=\"/AboutFDA/WorkingatFDA/default.htm\" title=\"Careers\">Careers</a></li>\r\n\t\t\t\t\t\t\t<li><a href=\"/AboutFDA/Transparency/Basics/default.htm\" title=\"FDA Basics\">FDA Basics</a></li>\r\n\t\t\t\t\t\t\t<li><a href=\"/RegulatoryInformation/FOI/default.htm\" title=\"Freedom of Information Act\">FOIA</a></li>\r\n\t\t\t\t\t\t\t<li><a href=\"/AboutFDA/WorkingatFDA/NoFEARAct/default.htm\" title=\"No FEAR Act\">No FEAR Act</a></li>\r\n\t\t\t\t\t\t\t<li><a href=\"/SiteMap/default.htm\" title=\"Site Map\">Site Map</a></li>\r\n\t\t\t\t\t\t\t<li><a href=\"/AboutFDA/AboutThisWebsite/ucm523730.htm\" title=\"Nondiscrimination\">Nondiscrimination</a></li>\r\n\t\t\t\t\t\t\t<li class=\"last\"><a href=\"/AboutFDA/AboutThisWebsite/WebsitePolicies/default.htm\" title=\"Website Policies\">Website Policies</a></li>\r\n\t\t\t\t\t\t</ul>\r\n\t\t\t\t\t</div>\r\n\t\t\t\t\t<div id=\"footer-fdalogo\">\r\n\t\t\t\t\t\t<a href=\"http://www.fda.gov\" title=\"FDA Homepage\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/fda-square-white-small.png\" alt=\"FDA\" title=\"FDA Homepage\"/></a>\r\n\t\t\t\t\t</div>\r\n\t\t\t\t</div>\r\n\t\t\t\t<!-- ## END footer-heading ## -->\r\n\t\t\t\t<!-- ## ADDED footer-content ## -->\r\n\t\t\t\t<div id=\"footer-content\" class=\"three-column\">\r\n\t\t\t\t\t<div id=\"footer-fda\" class=\"first\">\r\n\t\t\t\t\t\t<div class=\"footer-header\">U.S. Food and Drug Administration</div>\r\n\t\t\t\t\t\t<div class=\"address\">\r\n\t\t\t\t\t\t\t10903 New Hampshire Avenue <br/>\r\n\t\t\t\t\t\t\tSilver Spring, MD 20993 <br/>\r\n\t\t\t\t\t\t\tPh. 1-888-INFO-FDA (1-888-463-6332)<br/>\r\n\t\t\t\t\t\t\t<a href=\"/AboutFDA/ContactFDA/default.htm\" title=\"Contact FDA\">Contact FDA</a>\r\n\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t<div id=\"social-links\" class=\"hover-fade\">\r\n\t\t\t\t\t\t\t<ul class=\"list-horizontal\">\r\n\t\t\t\t\t\t\t\t<li><a href=\"http://www.usa.gov\" title=\"USA.gov\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_footer_logo_usagov.png\" alt=\"USA.gov\" title=\"USA.gov\"/></a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/AboutFDA/ContactFDA/StayInformed/GetEmailUpdates/default.htm\" title=\"Subscribe to E-mails\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_footer_icon_email.png\" alt=\"E-mail\" title=\"Subscribe to E-mails\"/></a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/AboutFDA/ContactFDA/StayInformed/RSSFeeds/default.htm\" title=\"Subscribe to RSS Feeds\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_footer_icon_rss.png\" alt=\"RSS\" title=\"Subscribe to RSS Feeds\"/></a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"https://twitter.com/US_FDA\" title=\"Follow FDA on Twitter\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_footer_icon_twitter.png\" alt=\"Twitter\" title=\"Follow FDA on Twitter\"/></a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"https://www.facebook.com/FDA\" title=\"Follow FDA on Facebook\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_ftr_icon_facebook.png\" alt=\"Facebook\" title=\"Follow FDA on Facebook\" /></a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"http://www.youtube.com/user/USFoodandDrugAdmin\" title=\"View FDA Videos\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_footer_icon_youtube.png\" alt=\"YouTube\" title=\"View FDA Videos\"/></a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"http://www.flickr.com/photos/fdaphotos/\" title=\"View FDA Photostream on Flickr\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_footer_icon_flickr.png\" alt=\"Flickr\" title=\"View FDA Photostream on Flickr\"></a></li>\r\n\t\t\t\t\t\t\t</ul>\r\n\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t<div id=\"footer-audience\">\r\n\t\t\t\t\t\t\t<ul class=\"list-horizontal\">\r\n\t\t\t\t\t\t\t\t<li class=\"first\"><a href=\"/ForFederalStateandLocalOfficials/default.htm\" title=\"For Government\">For Government</a></li>\r\n\t\t\t\t\t\t\t\t<li class=\"last\"><a href=\"/NewsEvents/default.htm\" title=\"For Press\">For Press</a></li>\r\n\t\t\t\t\t\t\t</ul>\r\n\t\t\t\t\t\t</div>\r\n\t\t\t\t\t</div>\r\n\t\r\n\t\t\t\t<div id=\"footer-links\" class=\"second\">\r\n\t\t\t\t\t\t<div>\r\n\r\n\t\t\t\t\t\t\t  <ul class=\"list-no-bullets\">\r\n\t\t\t\t\t\t\t\t<li><a href=\"/CombinationProducts/default.htm\" title=\"Combination Products\">Combination Products</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/AdvisoryCommittees/default.htm\" title=\"Advisory Committees\">Advisory Committees</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/ScienceResearch/default.htm\" title=\"Science &amp; Research\">Science & Research</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/RegulatoryInformation/default.htm\" title=\"Regulatory Information\">Regulatory Information</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/Safety/default.htm\" title=\"Safety\">Safety</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/EmergencyPreparedness/default.htm\" title=\"Emergency Preparedness\">Emergency Preparedness</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/InternationalPrograms/default.htm\" title=\"International Programs\">International Programs</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/NewsEvents/default.htm\" title=\"News &amp; Events\">News & Events</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/Training/default.htm\" title=\"Training and Continuing Education\">Training and Continuing Education</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/ICECI/default.htm\" title=\"Inspections/Compliance\">Inspections/Compliance</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/ForFederalStateandLocalOfficials/default.htm\" title=\"State &amp; Local Officials\">State & Local Officials</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/ForConsumers/default.htm\" title=\"Consumers\">Consumers</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/ForIndustry/default.htm\" title=\"Industry\">Industry</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/ForHealthProfessionals/default.htm\" title=\"Health Professionals\">Health Professionals</a></li>\r\n\t\t\t\t\t\t\t\t<li><a href=\"/AboutFDA/AboutThisWebsite/ucm450631.htm\">FDA Archive</a></li>\r\n\t\t\t\t\t\t\t\t</ul>\r\n\r\n\t\t\t\t\t\t</div>\r\n\t\t\t\t\t</div>\r\n\t\t\t\t\t\r\n\t\t\t\t\t<div id=\"footer-hhs\" class=\"third\">\r\n\t\t\t\t\t\t<div class=\"footer-header\"><a href=\"http://www.hhs.gov\" title=\"U.S. Department of Health &amp; Human Services\"><img src=\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_footer_hhslogo.png\" alt=\"U.S. Department of Health &amp; Human Services\" title=\"U.S. Department of Health &amp; Human Services\"/></a></div>\r\n\r\n\t\t\t\t\t</div>\r\n\t\t\t\t\t<div class=\"clearfloat\">&nbsp;</div>\r\n\t\t\t\t</div>\r\n\t\t\t\t<!-- ## END footer-content ## -->\r\n\t\t\t\t<!-- ==== BEGIN Footnote(s) ==== -->\r\n\t\t\t\t<div id=\"footnote\"><h2>Links on this page:</h2><div></div></div>\r\n\t\t\t\t<!-- ==== END Footnote(s) ==== -->\r\n\t\t\t\t<!-- ==== BEGIN Page Tools Bottom ==== -->\r\n\t\t\t\t<!-- ## REMOVED pagetools_bottom ## -->\r\n\t\t\t\t<!-- ==== END Page Tools Bottom ==== -->\r\n\t\t\t\t<!-- ## REMOVED footer-menu ## -->\r\n\t\t\t<!--googleon: index-->\r\n\t\t\t</div>\r\n\t\t\t<script type=\"text/javascript\">\r\n\t\t\t$(function () {\r\n\t\t\t\tif(!($(\"#DrugShortage_sortid\").length || $(\"#WarningLetter_sortid\").length))\r\n\t\t\t\t{\r\n\t\t\t\t\tif ($(\".tablesorter\").length > 0)\r\n\t\t\t\t\t{\r\n\t\t\t\t\t\t$(\".tablesorter\").footable({\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t});\t\t\r\n\t\t\t\t\t}\r\n\t\t\t\t}\t\t\r\n\t\t\t\t});\r\n\t\t\t</script>\r\n\t\t\t<!--==== END PAGE FOOTER ==== -->\r\n\t\t</div> <!--outerwrapper-->\r\n\r\n<div class=\"clearfloat\">\r\n      \r\n    </div>\r\n  </div>\r\n  <div id=\"bottom_corner\" class=\"box_bottom\"></div> \r\n   <div class=\"clearfloat\">\r\n    \r\n  </div>\r\n\r\n<script type=\"text/javascript\">\r\n\tvar cid_id, cid_item, cid_class, content_page = 0;\r\n\tvar breakout = false;\r\n\tvar cid = window.location.href.split(\"/\");\r\n\tvar cid_filename = cid[cid.length - 1];\r\n\tif(cid_filename.toLowerCase() == \"default.htm\" || cid_filename.toLowerCase() == \"index.htm\" )\r\n\t{\r\n\t\tcid_id = document.getElementById(\"left_nav_4983\");\r\n\t\tif(cid_id != null)\r\n\t\t{\r\n\t\t\tif(cid_id.className == \"sidemenu_parent\")\r\n\t\t\t{\r\n\t\t\t  breakout = true;\t\t\t \r\n\t\t\t}\r\n\t\t} \r\n\t}\r\n\telse\r\n\t{\r\n\t\tcid_item = cid_filename.split(\".\");\r\n\t\tcid_id = document.getElementById(cid_item[0].toUpperCase());\r\n\t\tcontent_page = 1;\t\r\n\t}\r\n\tif(breakout == false)\r\n\t{\r\n\t\tif (cid_id && content_page == 1) {\r\n\t\t\tvar cid_img_text=\"<div id=\\\"doc-select-arrow\\\" > <img src=\\\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_arrow.gif\\\" alt=\\\"Current Page is:\\\" />\";\r\n\t\t\tvar cid_id_innertext = cid_id.innerHTML; \r\n\t\t\tcid_img_text += cid_id_innertext;\r\n\t\t\tcid_id.innerHTML = cid_img_text+\"<div class=\\\"clearfloat\\\"></div></div>\";\t\t\r\n\t\t}\r\n\t\telse if(cid_id)\r\n\t\t{\r\n\t\t    var cid_img_text=\"<div id=\\\"doc-select-arrow-two\\\" ><img src=\\\"/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_arrow.gif\\\" alt=\\\"Current Page is:\\\" />\";\r\n\t\t\tvar cid_id_innertext = cid_id.innerHTML;\r\n\t\t\t\r\n\t\t\tif((cid_id_innertext.toLowerCase()).indexOf(\"<ul>\") >= 0)\r\n\t\t\t{\r\n\t\t\t  var indexer = (cid_id_innertext.toLowerCase()).indexOf(\"<ul>\");\r\n\t\t\t  var beg = cid_id_innertext.substring(0, indexer);\r\n\t\t\t  var end = cid_id_innertext.substring(indexer);\r\n\t\t\t  cid_id.innerHTML = cid_img_text + beg + \"<div class=\\\"clearfloat\\\"></div></div>\" + end;\t\r\n\t\t\t}\r\n\t\t\telse\r\n\t\t\t{\r\n\t\t\t\tcid_img_text += cid_id_innertext;\r\n\t\t\t\tcid_id.innerHTML = cid_img_text+\"<div class=\\\"clearfloat\\\"></div></div>\";\r\n\t\t\t}\r\n\t\t}\r\n\t}\r\n</script>\r\n\r\n\t\t</div>\r\n</body>\r\n</html>\r\n", "expected-search-type": "t"}